Jiri Dolina1, Lumir Kunovsky1,2, Radek Kroupa1, Karel Stary1, Petr Jabandziev3,4, Tereza Nesporova1, Karel Maca5, Tomas Andrasina6, Filip Marek2, Zdenek Kala2, Jitka Vaculova1, David Said7, Martina Zapletalova8,9, Jan Lochman8,9, Hana Palova Noskova3, Ondrej Slaby3,10, Lydie Izakovicova Holla8,11, Petra Borilova Linhartova8,12. 1. Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. 2. Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. 3. Central European Institute of Technology, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic. 4. Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Cernopolni 9, 61300, Brno, Czech Republic. 5. Department of Neurosurgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. 6. Department of Radiology and Nuclear Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. 7. Department of Pathology, University Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. 8. Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic. 9. Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic. 10. Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic. 11. Clinic of Stomatology, Institution Shared with St. Anne´s Faculty Hospital, Faculty of Medicine, Masaryk University, Pekarska 53, 656 91, Brno, Czech Republic. 12. Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic.
Abstract
BACKGROUND: Acromegaly is a disorder associated with hypersecretion of growth hormone, most usually caused by a pituitary adenoma. Dysmotility of the gastrointestinal tract has been reported in acromegalic patients. Achalasia is a disorder characterized by aperistalsis of the oesophagus with incomplete lower oesophageal sphincter relaxation and whose aetiology remains unknown. Mutations in some genes have previously been associated with the development of acromegaly or achalasia. The study aims were to analyse mutations in selected genes in a woman having both of these diseases, to identify their aetiological factors, and to suggest explanations for the co-incidence of acromegaly and achalasia. METHODS AND RESULTS: A female patient with acromegaly, achalasia, and a multinodular thyroid gland with hyperplastic colloid nodules underwent successful treatment of achalasia via laparoscopic Heller myotomy, a thyroidectomy was performed, and the pituitary macroadenoma was surgically excised via transnasal endoscopic extirpation. Germline DNA from the leukocytes was analysed by sequencing methods for a panel of genes. No pathogenic mutation in AAAS, AIP, MEN1, CDKN1B, PRKAR1A, SDHB, GPR101, and GNAS genes was found in germline DNA. The somatic mutation c.601C>T/p.R201C in the GNAS gene was identified in DNA extracted from a tissue sample of the pituitary macroadenoma. CONCLUSIONS: We here describe the first case report to our knowledge of a patient with both acromegaly and achalasia. Association of acromegaly and soft muscle tissue hypertrophy may contribute to achalasia's development. If one of these diagnoses is determined, the other also should be considered along with increased risk of oesophageal and colorectal malignancy.
BACKGROUND: Acromegaly is a disorder associated with hypersecretion of growth hormone, most usually caused by a pituitary adenoma. Dysmotility of the gastrointestinal tract has been reported in acromegalic patients. Achalasia is a disorder characterized by aperistalsis of the oesophagus with incomplete lower oesophageal sphincter relaxation and whose aetiology remains unknown. Mutations in some genes have previously been associated with the development of acromegaly or achalasia. The study aims were to analyse mutations in selected genes in a woman having both of these diseases, to identify their aetiological factors, and to suggest explanations for the co-incidence of acromegaly and achalasia. METHODS AND RESULTS: A female patient with acromegaly, achalasia, and a multinodular thyroid gland with hyperplastic colloid nodules underwent successful treatment of achalasia via laparoscopic Heller myotomy, a thyroidectomy was performed, and the pituitary macroadenoma was surgically excised via transnasal endoscopic extirpation. Germline DNA from the leukocytes was analysed by sequencing methods for a panel of genes. No pathogenic mutation in AAAS, AIP, MEN1, CDKN1B, PRKAR1A, SDHB, GPR101, and GNAS genes was found in germline DNA. The somatic mutation c.601C>T/p.R201C in the GNAS gene was identified in DNA extracted from a tissue sample of the pituitary macroadenoma. CONCLUSIONS: We here describe the first case report to our knowledge of a patient with both acromegaly and achalasia. Association of acromegaly and soft muscle tissue hypertrophy may contribute to achalasia's development. If one of these diagnoses is determined, the other also should be considered along with increased risk of oesophageal and colorectal malignancy.
Authors: Janette Furuzawa-Carballeda; Samuel Torres-Landa; Miguel Ángel Valdovinos; Enrique Coss-Adame; Luis A Martín Del Campo; Gonzalo Torres-Villalobos Journal: World J Gastroenterol Date: 2016-09-21 Impact factor: 5.742